NDC 57894-505

Darzalex IV 100 mg per 5 mL injection, solution, concentrate

On the label: Janssen Biotech, Inc..

Switzerland: 2Denmark: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Cilag AGSchaffhausen, SwitzerlandMakes it, tests it, packages it and labels it No problems foundNov 21, 2025 · 8 inspections
FUJIFILM Diosynth Biotechnologies Denmark ApSHillerod, DenmarkMakes the active ingredient Problems found, fixed voluntarilyJun 30, 2023 · 5 inspections
Lonza AGVisp, SwitzerlandMakes it and tests it Not inspected on record
Eurofins Biolab SrlVimodrone, ItalyTests it Problems found, fixed voluntarilySep 13, 2024 · 5 inspections
Janssen Biologics B.V.Leiden, NetherlandsTests it Problems found, fixed voluntarilyJun 1, 2023 · 7 inspections
Janssen Biotech, Inc.Malvern, PA, United StatesTests it Problems found, fixed voluntarilyJul 29, 2025 · 13 inspections
Janssen Pharmaceutica NVBeerse, BelgiumPackages it Problems found, fixed voluntarilySep 5, 2025 · 8 inspections
Janssen Sciences Ireland UCCO Cork, IrelandTests it Problems found, fixed voluntarilyJan 12, 2024 · 5 inspections
Lonza AGVisp, SwitzerlandTests it Problems found, fixed voluntarilyMar 28, 2023 · 7 inspections

Product details

Generic drug
Daratumumab: every company that makes it
Form
injection, solution, concentrate, intravenous
Strength
100 mg per 5 mL
Approval
BLA BLA761036
On the market since
Oct 15, 2021
Package NDCs
57894-505-05 57894-505-20
Official label
DailyMed (National Library of Medicine), updated Sep 21, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?